1. Home
  2. MTNB vs VERO Comparison

MTNB vs VERO Comparison

Compare MTNB & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTNB
  • VERO
  • Stock Information
  • Founded
  • MTNB 2013
  • VERO N/A
  • Country
  • MTNB United States
  • VERO Canada
  • Employees
  • MTNB N/A
  • VERO N/A
  • Industry
  • MTNB Biotechnology: Pharmaceutical Preparations
  • VERO Medical/Dental Instruments
  • Sector
  • MTNB Health Care
  • VERO Health Care
  • Exchange
  • MTNB Nasdaq
  • VERO Nasdaq
  • Market Cap
  • MTNB 3.0M
  • VERO 2.4M
  • IPO Year
  • MTNB N/A
  • VERO N/A
  • Fundamental
  • Price
  • MTNB $0.58
  • VERO $0.36
  • Analyst Decision
  • MTNB Hold
  • VERO
  • Analyst Count
  • MTNB 1
  • VERO 0
  • Target Price
  • MTNB N/A
  • VERO N/A
  • AVG Volume (30 Days)
  • MTNB 1.0M
  • VERO 261.4K
  • Earning Date
  • MTNB 03-26-2025
  • VERO 03-31-2025
  • Dividend Yield
  • MTNB N/A
  • VERO N/A
  • EPS Growth
  • MTNB N/A
  • VERO N/A
  • EPS
  • MTNB N/A
  • VERO N/A
  • Revenue
  • MTNB N/A
  • VERO $67,200,000.00
  • Revenue This Year
  • MTNB N/A
  • VERO N/A
  • Revenue Next Year
  • MTNB N/A
  • VERO $4.39
  • P/E Ratio
  • MTNB N/A
  • VERO N/A
  • Revenue Growth
  • MTNB N/A
  • VERO N/A
  • 52 Week Low
  • MTNB $0.48
  • VERO $0.28
  • 52 Week High
  • MTNB $21.50
  • VERO $2.22
  • Technical
  • Relative Strength Index (RSI)
  • MTNB 43.31
  • VERO 45.20
  • Support Level
  • MTNB $0.53
  • VERO $0.31
  • Resistance Level
  • MTNB $0.70
  • VERO $0.39
  • Average True Range (ATR)
  • MTNB 0.06
  • VERO 0.04
  • MACD
  • MTNB 0.00
  • VERO -0.00
  • Stochastic Oscillator
  • MTNB 13.92
  • VERO 39.62

About MTNB Matinas Biopharma Holdings Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

About VERO Venus Concept Inc.

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Share on Social Networks: